ArticleBMJ case reports2025
Tubulointerstitial nephritis and uveitis post COVID-19 infection in an adult.
Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A woman in her 50s contracted COVID-19 and initially presented a few weeks afterwards with left eye pain and redness. She was diagnosed with uveitis and treated with glucocorticoid eye drops. Renal impairment was found on laboratory investigations performed following the diagnosis of uveitis, and urine testing showed proteinuria. Serological testing showed no cause for the new findings, and renal imaging was unremarkable. A renal biopsy was conducted and histology was consistent with tubulointerstitial nephritis. A diagnosis of tubulointerstitial nephritis with uveitis (TINU) was established, and she was given prednisolone, with resolution of proteinuria and improvement in renal function. While TINU is rare but well described in children, it can also uncommonly be a cause of renal impairment in adults post COVID-19 infection, similar to cases in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.